David Nierengarten: Well-Funded VC's Are Betting Heavily on Biotechs - Wedbush

08/15/2019

David Nierengarten: Well-Funded VC’s Are Betting Heavily on Biotechs

For more on David Nierengarten’s comments: These 28 biotech startups have attracted the most VC cash, making them prime candidates for an acquisition or IPO

Recent Posts:

Recent Posts

Contact us to learn how we can partner for your financial success.